Ultimate Telemedicine: Expert helps treat astronaut’s blood clot during NASA mission

“My first reaction when NASA reached out to me was to ask if I could visit the International Space Station (ISS) to examine the patient myself,” said Stephan Moll, MD, UNC School of Medicine blood clot expert and long-time NASA enthusiast. “NASA told me they couldn’t get me up to space quickly enough, so I proceeded with the evaluation and treatment process from here in Chapel Hill.”

Moll was the only non-NASA physician NASA consulted when it was discovered that an astronaut aboard the ISS had a deep vein thrombosis (DVT) — or blood clot — in the jugular vein of their neck. The astronaut’s identity is being kept anonymous for privacy reasons, so identifying information such as when this event happened is being omitted from the case study. We do know that the astronaut was two months into a six-month mission on the ISS when the DVT was discovered.

This was the first time a blood clot had been found in an astronaut in space, so there was no established method of treatment for DVT in zero gravity. Moll, a member of the UNC Blood Research Center, was called upon for his vast knowledge and treatment experience of DVT on Earth.

“Normally the protocol for treating a patient with DVT would be to start them on blood thinners for at least three months to prevent the clot from getting bigger and to lessen the harm it could cause if it moved to a different part of the body such as the lungs,” Moll said. “There is some risk when taking blood thinners that if an injury occurs, it could cause internal bleeding that is difficult to stop. In either case, emergency medical attention could be needed. Knowing there are no emergency rooms in space, we had to weigh our options very carefully.”

Moll and a team of NASA doctors decided blood thinners would be the best course of treatment for the astronaut. They were limited in their pharmaceutical options, however. The ISS keeps only a small supply of various medicines on board, and there was a limited amount of the blood thinner Enoxaparin (Lovenox®) available. Moll advised NASA on what dosage of Enoxaparin would effectively treat the DVT while also lasting long enough, until NASA could get a new shipment of drugs — which Moll helped select — to the ISS.

The course of treatment with Enoxaparin — a drug delivered by an injection into the skin — lasted for around 40 days. On day 43 of the astronaut’s treatment, a supply of Apixaban (Eliquis®) — a pill taken orally- was delivered to the ISS by a supply spacecraft.

Throughout the treatment process, which lasted more than 90 days, the astronaut performed ultrasounds on their own neck with guidance from a radiology team on Earth in order to monitor the blood clot. Moll was also able to speak to the astronaut during this period through email and phone calls.

“When the astronaut called my home phone, my wife answered and then passed the phone to me with the comment, ‘Stephan, a phone call for you from space.’ That was pretty amazing,” said Moll. “It was incredible to get a call from an astronaut in space. They just wanted to talk to me as if they were one of my other patients. And amazingly the call connection was better than when I call my family in Germany, even though the ISS zips around Earth at 17,000 miles per hour.”

Four days before the astronaut’s journey home to Earth, they stopped taking Apixaban. Moll and his NASA counterparts made that decision because of how physically demanding and potentially dangerous the re-entry process can be for astronauts, and they did not want an injury to be exacerbated by the use of blood thinners. The astronaut landed safely on Earth and the blood clot required no more treatment.

This astronaut’s blood clot was asymptomatic — they didn’t have any symptoms that would have otherwise made them aware of the clot. The DVT was discovered when the astronaut was taking ultrasounds of their neck for a research study on how body fluid is redistributed in zero gravity. If it wasn’t for the study, there’s no telling what the outcome could have been. That’s why Moll continues to work with NASA and says there’s a need for more research of how blood and blood clots behave in space.

“Is this something that is more common in space?” posed Moll. “How do you minimize risk for DVT? Should there be more medications for it kept on the ISS? All of these questions need answering, especially with the plan that astronauts will embark on longer missions to the moon and Mars.”

Story Source:

Materials provided by University of North Carolina Health Care. Note: Content may be edited for style and length.

Share Button

Research gaps in environmental science disciplines across the Arctic

Global warming is driving rapid environmental change in the Arctic. “To understand these changes, field measurements that adequately represent environmental variation across the Arctic as a whole are crucial,” says PhD student Anna-Maria Virkkala from the University of Helsinki.

A new study by researchers from University of Helsinki and Lund University shows that northern Arctic regions remain under-sampled and provides detailed maps of potential new sampling locations for each environmental science discipline across the Arctic.

The changing Arctic requires a sampling strategy for the future

Doing field work in the harsh Arctic conditions is not easy. Resources and accessibility strongly constrain Arctic research. Understanding what kind of conditions and regions remain under-studied is important when researchers plan new field campaigns.

However, studies dealing with the representativeness of sampling have been conducted mainly for very specific fields, or in smaller regions. Thus, the current state of field sampling across broad environmental science disciplines across the Arctic has not been fully understood.

“We utilize an existing literature database of around 1 800 field studies across the Arctic,” says Dan Metcalfe, a senior lecturer in Lund University. This database contains information about the field sampling locations and citations, including their primary discipline/s within environmental sciences featured in the article.

Open spatial data sets describing topography, vegetation, and soils were used to characterize the environmental conditions of each sampling location. “The availability of these data sets has increased during the past decade which allows us to explore the environmental coverage of Arctic field sampling comprehensively,” says a Post-Doc researcher Hakim Abdi from Lund University.

New field studies are needed in the northernmost Arctic regions

The study shows that more research is needed particularly in the Canadian Arctic Archipelago, northern Greenland, northern Taimyr, and central and eastern Siberia. These under-sampled regions are characterized by cold soils and climate and modest vegetation cover. Many of these regions are predicted to experience rapid permafrost thaw and vegetation shifts due to global warming in the future. The lack of data from these conditions suggests that we do not necessarily understand the whole range of changes that the global warming might cause.

Differences in sampling across environmental science disciplines

There are differences in the representativeness of sampling locations across environmental science disciplines. Sampling locations in Botany and Biogeochemistry cover environmental gradients the best, and Microbiology, Meteorology, Geosciences and Geographic Information Systems / Remote Sensing / Modeling have the largest research gaps across the Arctic. Although northern Alaska and Fennoscandia remained the best sampled regions, research gaps were found even in central Arctic Alaska or southern Arctic Fennoscandia in some disciplines.

Let’s keep exploring the Arctic together

Luckily, many of these under-sampled regions are close to existing infrastructure, so making a change is possible. “We hope these results will help prioritize future research efforts across all environmental science disciplines, thus increasing our knowledge about the Arctic environmental change,” summarizes Professor Miska Luoto from University of Helsinki.

Story Source:

Materials provided by University of Helsinki. Original written by Riitta-Leena Inki. Note: Content may be edited for style and length.

Share Button

Health24.com | WATCH: How smokers could drastically improve their health if they decide to quit

Stringr

If the financial benefits of quitting smoking is not enough to convince you, experts are now suggesting that quitting smoking could drastically improve your health.

Research has shown that when people quit smoking, it can lower their risk of cardiovascular disease by up to 40%. 

Image credit: iStock

Share Button

Health24.com | You won’t get sued if you do CPR, review suggests

Are you worried about getting sued if you provide bystander CPR in a public place?

Don’t be, surprising new research suggests: You’re more likely to get sued if you don’t intervene.

Allegation of negligence

Dr Travis Murphy undertook the most comprehensive review to date of jury verdicts, settlements, and appellate opinions focused on lawsuits involving cardiopulmonary resuscitation (CPR). His team analysed 170 cases launched between 1989 and 2019 across all 50 states.

And, Murphy said, the data shows that “no non-medical person has been successfully sued for providing bystander CPR” to those who appear to be in cardiac arrest or trouble.

“There have been far more cases brought due to delays in [providing] CPR rather than for providing CPR,” he added.

Murphy, who is an emergency medicine attending physician and a fellow in surgical critical care at the University of Florida in Gainesville, said nearly all the CPR cases (167 out of 170) involved an allegation of negligence, namely not providing CPR when it might’ve helped. In sum, those cases generated punitive damages of roughly $620 million (±R9281 million).

Of the three cases in which defendants were charged with battery assault because they did administer CPR, only one was convicted. And that was because “the patient already had a signed ‘Do Not Resuscitate’ order and received CPR anyway in their nursing home,” Murphy explained. The nursing home paid more than $121 000 (±R1 811 000) in damages.

The other two cases were ruled in favour of the bystanders. And that, said Murphy, suggests that bystanders are very well protected by “Good Samaritan” laws.

‘Duty to act’ laws

“The laws vary from state to state,” he explained, and some states do have limitations in place. For example, Kentucky statutes only protect bystanders who offer CPR assistance if they are medically trained.

But most states fully protect bystanders who sincerely try to help, Murphy stressed. Some states even have “Duty to Act” laws that establish fines specifically for bystanders who are medically trained to provide CPR but choose not to help when an emergency unfolds. (Minnesota, Rhode Island and Vermont are three such examples.)

The findings come as little surprise to Dr Michael Kurz, an associate professor in the department of emergency medicine with UAB Medicine and the Alabama Resuscitation Center in Birmingham.

“There is good scientific literature that suggests that the risk of liability when you stand up in this regard is miniscule, if it exists at all,” Kurz said.

But what should a bystander do if he/she is not trained in CPR?

Murphy said, “Ideally, we would like to see more people trained in CPR. But understanding that not everyone will be trained, calling 911 immediately would be the best course of action, since this is so time-sensitive.”

Any assistance better than none

That thought was seconded by Kurz, who also serves as chair of the American Heart Association’s task force for telecommunicator CPR.

“In general, we encourage the lay public to render aid that they feel comfortable with,” he said. “But any assistance is better than no assistance. Because the alternative in the face of a cardiac arrest is the patient dies if no assistance is given,” Kurz added.

“So you can call 911, and the dispatcher can send appropriate help. But then, in addition, [they] can also provide ‘just in time’ simple CPR instructions over the phone within 20 seconds. That’s all you need to be instructed on how to do it in an emergency, with absolutely no prior training,” Kurz explained.

Murphy’s findings are scheduled for presentation at the American Heart Association meeting in Philadelphia.

Research presented at medical meetings should be considered preliminary until published in a peer-reviewed journal.

Image credit: iStock

Share Button

Some learning is a whole-brain affair

Researchers at Johns Hopkins Medicine have successfully used a laser-assisted imaging tool to “see” what happens in brain cells of mice learning to reach out and grab a pellet of food. Their experiments, they say, add to evidence that such motor-based learning can occur in multiple areas of the brain, even ones not typically associated with motor control.

“Scientists should be looking at the entire brain to understand specific types of learning,” says Richard Huganir, Ph.D., Bloomberg Distinguished Professor and Director of the Solomon H. Snyder Department of Neuroscience at the Johns Hopkins University School of Medicine. “Different parts of the brain contribute to learning in different ways, and studying brain cell receptors can help us decipher how this works.”

The work, say the researchers, may ultimately inform efforts to develop treatments for learning-based and neurocognitive disorders.

In a report on the work, appearing online Dec. 31 in Neuron, Huganir and his research team say they focused on AMPA-type glutamate receptors, or AMPARs, key molecules that help send messages between brain cells called neurons. AMPARs function like antennas that form along the surface of a particular spot on neurons called a synapse, where it receives molecular signals from other neurons.

To monitor and measure AMPAR levels in mouse brains, scientists previously had to dissect the organ before and after a learning experiment and compare differences. Now, scientists have ways to directly view the brain during learning, recording thousands of synapses at a time.

In the new experiments, scientists injected DNA-encoding AMPARs carrying a fluorescent tag into the brains of mice, and used an electrical pulse to get neurons to absorb the AMPAR DNA. Next, with a tool called two-photon microscopy, the scientists used a laser — essentially an intensely focused beam of light — to detect and measure the amount of fluorescence coming from the tagged AMPARs.

More fluorescence is an indication of increased AMPAR activity and messaging between neurons, a good sign that learning and memory building is taking place in those neurons, Huganir says.

To “see” what learning looked like in the test animals’ neurons, Huganir’s team trained mice to reach for and grab a food pellet placed just outside their cage using their paws. Normally, mice get pellets with their mouths.

While the mice were learning how to reach for the pellet, the scientists found an approximately 20% increase in the activity of AMPARs in an area of the brain known as the motor cortex, which is known for controlling and precisely moving muscles. On neurons, the AMPARs look like lights on a Christmas tree and glow brighter with increasing activity.

But the experiments also showed the same increase in AMPAR activity levels in the visual cortex too.

“This made sense because vision is very important for motor control,” says Richard Roth, Ph.D., currently a postdoctoral fellow at Stanford University, but who performed experiments for this study as a graduate student in Huganir’s laboratory.

“So, we did the same experiment again, but with the lights switched off,” says Roth.

Using infrared light, which the mice couldn’t see, the mice eventually learned to successfully grab the food, but there was a smaller increase (10%) in the activity of AMPARs in the visual cortex.

“We believe the mice brains are using different sets of sensory cues in the dark to learn the motor task, including touch and smell, enabling these other senses to take over,” says Roth.

Next, the research team repeated the experiments using specialized light-activated modulators to shut down neurons in either the motor or visual cortex.

If the mice were trained to get the pellet with the room lights on, the mice could not complete the task if their visual cortex was shut down. “Clearly, these mice relied on learning centralized in their visual cortex to reach the pellet,” says Roth.

However, mice initially trained to grab the pellet in the dark could still complete the task, even if their visual cortex was shut down.

“We’ve traditionally thought that motor-based learning happens solely in the motor part of the brain, but our studies and others now show that it’s not as specific as we had thought. There is more of a brainwide effect in learning,” says Roth.

Huganir notes that among the genes that control neuronal receptors involved in learning is SYNGAP. His and others’ research has shown that when the gene is mutated, it contributes to conditions including intellectual disability, autism and schizophrenia — all conditions marked in part by disrupted thinking and learning.

Share Button

Health24.com | WATCH: Exercising while restricting calories could be bad for bone health

02 January 2020

WATCH: Exercising while restricting calories could be bad for bone health

New research shows that being in a constant caloric deficit combined with intense exercise can hurt your bones.

Stringr

Calorie-restricted diets have gained popularity over time due to the fact that it often delivers results very quickly.

Restricting calories is the practice of eliminating or limiting dietary energy intake.

Now, experts have found that a constant caloric deficit can harm the bones when combined with intense exercise. 

Image credit: iStock

NEXT ON HEALTH24X

Live healthier

Share Button

Eating disorder hospital admissions rise sharply

NHS figures show admissions have risen by more than a third over the last two years.

Share Button

All global sustainability is local

Nations across the world are following a United Nations blueprint to build a more sustainable future — but a new study shows that blueprint leads less to a castle in the sky, and more to a house that needs constant remodeling.

Sustainability scientists have developed systematic and comprehensive assessment methods and performed the first assessment of a country’s progress in achieving all 17 UN Sustainable Development Goals (SDGs) not just as a nation, but also at the regional levels, and not just as a snapshot — but over time.

In “Assessing progress towards sustainable development over space and time” in this week’s Nature, scientists from Michigan State University (MSU) and in China show that indeed all sustainability, like politics, is local.

Even as a country can overall claim movement toward a sustainable future, areas within the country reflect the gains and losses in the struggle with poverty, inequality, climate, environmental degradation and for prosperity, and peace and justice. Most striking, the study found, is the disparities between developed regions and ones that are developing.

“We have learned that sustainability’s progress is dynamic and that sometimes gains in one important area can come at costs to another area, tradeoffs that can be difficult to understand but can ultimately hobble progress,” said Jianguo “Jack” Liu, MSU Rachel Carson Chair in Sustainability and senior author. “Whether it’s protecting precious natural resources, making positive economic change or reducing inequality — it isn’t a static score. We must carefully take a holistic view to be sure progress in one area isn’t compromised by setbacks in other areas.”

The group assessed China with methods that can be applied to other countries. China’s vast size and sweeping socioeconomic changes at national and provincial levels showed how progress in sustainability can shift. Between 2000 and 2015, China has improved its aggregated SDG score.

At the provincial level, however, there is a disparity between the country’s developed and developing regions. East China — which is home to the country’s economic boom — had a higher SDG Index score than the more rural west China in the 2000s. In 2015, south China had a higher SDG Index score than the industrialized and agricultural-intensive north China.

Zhenci Xu, a recent PhD graduate from MSU’s Center for Systems Integration and Sustainability (MSU-CSIS) who led the study, notes that countries are tasked with urgent goal of achieving sustainability even as populations grow, economies develop unevenly, natural resources like water and energy become scarce, land degrades, and income and gender inequities intensify.

Developed provinces had higher (and thus better) SDG Index scores than developing provinces throughout the study period of 2000-2015. But the average SDG Index scores in developing provinces were increasing faster compared to developed provinces.

“China’s eastern region began developing during the reform and opening-up policy in the late 70s to spur economic development along the coasts, which was accompanied by better social services,” Xu said. “In 1999, China started to address the rural western parts which had lagged in progress. That saw improvements both in infrastructure and ecological conservation, which seems to have boosted their sustainable development. The eastern parts have begun to struggle with the consequences of rapid economic growth — such as pollution and inequities.”

The authors note that overall sustainability is advancing thanks to better education, healthcare and environmental conservation policies. The study points out that even amidst progress, it is important to scrutinize what is happening at regional levels to know where to direct resources and attention.

Story Source:

Materials provided by Michigan State University. Note: Content may be edited for style and length.

Share Button

Alzheimer ‘tau’ protein far surpasses amyloid in predicting toll on brain tissue

Brain imaging of pathological tau-protein “tangles” reliably predicts the location of future brain atrophy in Alzheimer’s patients a year or more in advance, according to a new study by scientists at the UC San Francisco Memory and Aging Center. In contrast, the location of amyloid “plaques,” which have been the focus of Alzheimer’s research and drug development for decades, was found to be of little utility in predicting how damage would unfold as the disease progressed.

The results, published January 1, 2020 in Science Translational Medicine, support researchers’ growing recognition that tau drives brain degeneration in Alzheimer’s disease more directly than amyloid protein, and at the same time demonstrates the potential of recently developed tau-based PET (positron emission tomography) brain imaging technology to accelerate Alzheimer’s clinical trials and improve individualized patient care.

“The match between the spread of tau and what happened to the brain in the following year was really striking,” said neurologist Gil Rabinovici, MD, the Edward Fein and Pearl Landrith Distinguished Professor in Memory and Aging and leader of the PET imaging program at the UCSF Memory and Aging Center. “Tau PET imaging predicted not only how much atrophy we would see, but also where it would happen. These predictions were much more powerful than anything we’ve been able to do with other imaging tools, and add to evidence that tau is a major driver of the disease.”

Interest in Tau Growing as Amyloid-Based Therapies Stumble

Alzheimer’s researchers have long debated the relative importance of amyloid plaques and tau tangles — two kinds of misfolded protein clusters seen in postmortem studies of patients’ brains, both first identified by Alois Alzheimer in the early 20th century. For decades, the “amyloid camp” has dominated, leading to multiple high-profile efforts to slow Alzheimer’s with amyloid-targeting drugs, all with disappointing or mixed results.

Many researchers are now taking a second look at tau protein, once dismissed as simply a “tombstone” marking dying cells, and investigating whether tau may in fact be an important biological driver of the disease. In contrast to amyloid, which accumulates widely across the brain, sometimes even in people with no symptoms, autopsies of Alzheimer’s patients have revealed that tau is concentrated precisely where brain atrophy is most severe, and in locations that help explain differences in patients’ symptoms (in language-related areas vs. memory-related regions, for example).

“No one doubts that amyloid plays a role in Alzheimer’s disease, but more and more tau findings are beginning to shift how people think about what is actually driving the disease,” explained Renaud La Joie, PhD, a postdoctoral researcher in Rabinovici’s In Vivo Molecular Neuroimaging Lab, and lead author of the new study. “Still, just looking at postmortem brain tissue, it has been hard to prove that tau tangles cause brain degeneration and not the other way around. One of our group’s key goals has been to develop non-invasive brain imaging tools that would let us see whether the location of tau buildup early in the disease predicts later brain degeneration.”

Tau PET Scans Predict Locations of Future Brain Atrophy in Individual Patients

Despite early misgivings that tau might be impossible to measure in the living brain, scientists recently developed an injectable molecule called flortaucipir — currently under review by the FDA — which binds to misfolded tau in the brain and emits a mild radioactive signal that can be picked up by PET scans.

Rabinovici and collaborator William Jagust, MD, of UC Berkeley and Lawrence Berkeley National Laboratory, have been among the first to adopt tau PET imaging to study the distribution of tau tangles in the normally aging brain and in a smaller cross-sectional study of Alzheimer’s patients. Their new study represents the first attempt to test whether tau levels in Alzheimer’s patients can predict future brain degeneration.

La Joie recruited 32 participants with early clinical stage Alzheimer’s disease through the UCSF Memory and Aging Center, all of whom received PET scans using two different tracers to measure levels of amyloid protein and tau protein in their brains. The participants also received MRI scans to measure their brain’s structural integrity, both at the start of the study, and again in follow-up visits one to two years later.

The researchers found that overall tau levels in participants’ brains at the start of the study predicted how much degeneration would occur by the time of their follow up visit (on average 15 months later). Moreover, local patterns of tau buildup predicted subsequent atrophy in the same locations with more than 40 percent accuracy. In contrast, baseline amyloid-PET scans correctly predicted only 3 percent of future brain degeneration.

“Seeing that tau buildup predicts where degeneration will occur supports our hypothesis that tau is a key driver of neurodegeneration in Alzheimer’s disease,” La Joie said.

Notably, PET scans revealed that younger study participants had higher overall levels of tau in their brains, as well as a stronger link between baseline tau and subsequent brain atrophy, compared to older participants. This suggests that other factors — likely other abnormal proteins or vascular injuries — may play a larger role in late-onset Alzheimer’s, the researchers say.

Ability to Predict Brain Atrophy a ‘Valuable Precision Medicine Tool’

The results add to hopes that tau-targeting drugs currently under study at the UCSF Memory and Aging Center and elsewhere may provide clinical benefits to patients by blocking this key driver of neurodegeneration in the disease. At the same time, the ability to use tau PET to predict later brain degeneration could enable more personalized dementia care and speed ongoing clinical trials, the authors say.

“One of the first things people want to know when they hear a diagnosis of Alzheimer’s disease is simply what the future holds for themselves or their loved ones. Will it be a long fading of memory, or a quick decline into dementia? How long will the patient be able to live independently? Will they lose the ability to speak or get around on their own? These are questions we can’t currently answer, except in the most general terms,” Rabinovici said. “Now, for the first time, this tool could let us give patients a sense of what to expect by revealing the biological process underlying their disease.”

Rabinovici and his team also anticipate that the ability to predict future brain atrophy based on tau PET imaging will allow Alzheimer’s clinical trials to quickly assess whether an experimental treatment can alter the specific trajectory predicted for an individual patient, which is currently impossible due to the wide variability in how the disease progresses from individual to individual. Such insights could make it possible to adjust dosage or switch to a different experimental compound if the first treatment is not affecting tau levels or altering a patient’s predicted trajectory of brain atrophy.

“Tau PET could be an extremely valuable precision medicine tool for future clinical trials,” Rabinovici said. “The ability to sensitively track tau accumulation in living patients would for the first time let clinical researchers seek out treatments that can slow down or even prevent the specific pattern of brain atrophy predicted for each patient.”

Share Button

Health24.com | How cleaner air quickly brings about big health benefits

When people are breathing cleaner air, their health generally improves – rapidly, in some cases, a new review shows.

The report, from the Environmental Committee of the Forum of International Respiratory Societies (FIRS), details some of the evidence on air quality and human health. Overall, it concludes, people can reap a range of benefits when air pollution is cut – from fewer asthma attacks, to lower risks of heart attack and stroke, to a longer life expectancy.

Changes in ‘Olympic’ cities

Some of the effects are “quite striking”, said Dr Dean Schraufnagel, the report’s lead author and executive director of FIRS. He pointed to the example of changes made in cities hosting the Olympics – which, for a time, resulted in cleaner air and healthier residents.

For the 1996 Olympic Games in Atlanta, officials bumped up public transportation and closed downtown streets to private vehicles. As a result, peak daily ozone levels dropped by 28%, and over the next four weeks, the number of city children needing medical care for asthma attacks fell by more than 40%.

Similarly, when Beijing hosted the 2008 Olympics, the Chinese national government put three-month restrictions on traffic, as well as factory emissions. Air pollution plummeted, and within two months, there were declines in doctor visits for asthma and in deaths from heart disease and stroke.

“If you stop the pollution at its source, there are huge health benefits to be had,” said Schraufnagel, who is also a pulmonologist at the University of Illinois at Chicago.

Other examples come from factory shutdowns, according to the report. When a large steel mill in the Utah Valley closed for 13 months, fine-particle pollution fell by half, and hospital admissions for asthma, pneumonia and other lung diseases declined.

A wide range of effects

And the improvements were not limited to lung disease. Premature births were reduced, as was the area’s daily mortality rate.

That brings up a bigger point, Schraufnagel said: Dirty air has a wide range of effects on the human body.

“It affects the heart, the kidneys, the brain, and it’s associated with higher risks of heart disease, stroke, diabetes, dementia and many cancers,” Schraufnagel said.

People are not always aware of how important air quality is to our health, according to Dr Meredith McCormack, a spokeswoman for the American Lung Association.

“But when you think about it, we’re breathing in air every moment of every day, and the quality of that air is important,” said McCormack, who was not involved in the review.

She called the report “very informative”, bringing together examples of how air quality changes can affect the health of people of all ages, short- and long-term.

Relatively ‘easy’ steps can help

Does it all mean factories must close and traffic must be banned in downtowns? No, Schraufnagel said. The dramatic instances noted in the report point to the power of reducing air pollution, he said, and that can be achieved through many different measures.

“A coal-fired plant could switch to natural gas, for example,” Schraufnagel said. Or old diesel-powered buses can be replaced by “cleaner” ones powered by natural gas or electricity.

Even relatively “easy” steps can help, Schraufnagel added. A study found that when school buses spent less time idling, they spewed fewer fine particles and less carbon into the air around schools.

The standard argument against tougher air quality rules is economic, Schraufnagel noted. But even there, he said, evidence favours taking action.

‘Champions of cleaner air’

The US Clean Air Act, enacted in 1970, is credited with slashing emissions of air pollutants nationally, while gross domestic product kept growing.

The US Environment Protection Agency estimates that the “monetized” health benefits of the law have exceeded the costs by a factor of 32 to 1. Those benefits, valued at $2 trillion in 2020, were mainly attributed to fewer deaths related to air pollution, according to the report.

McCormack suggested that people try to be “champions of cleaner air, indoors and outdoors”. That can include banning smoking and using less energy at home, and advocating for local and national measures to reduce air pollution.

The findings were published in Annals of the American Thoracic Society.

Image credit: iStock

Share Button